Tennessee Medicaid Claimed Hundreds of Millions of Federal Funds for Certified Public Expenditures That Were Not in Compliance With Federal Requirements
More Than One-Third of Medicaid-Enrolled Children in Five States Did Not Receive Required Blood Lead Screening Tests
Most Medicare beneficiaries received telehealth services only from providers with whom they had an established relationship
Changes Made to States Medicaid Programs To Ensure Beneficiary Access to Prescriptions During the COVID-19 Pandemic
Minnesota Medicaid Managed Care Entities Used a Majority of Medicaid Funds Received for Medical Expenses and Quality Improvement Activities
Medicare Overpaid $636 Million for Neurostimulator Implantation Surgeries
Advisory Opinion 21-14
Advisory Opinion 21-13
High-expenditure Medicare drugs often qualified for Orphan Drug Act incentives designed to encourage the development of treatments for rare diseases
Advisory Opinion 21-12
An Ophthalmology Clinic in Florida: Audit of Medicare Payments for Eye Injections of Avastin, Eylea, and Lucentis
Colorado Did Not Invoice Rebates to Manufacturers for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations
CMS COVID-19 Data Included Required Information From the Vast Majority of Nursing Homes, but CMS Could Take Actions To Improve Completeness and Accuracy of the Data
Medicare Beneficiaries Hospitalized With COVID-19 Experienced a Wide Range of Serious, Complex Conditions
Oklahoma Oversight of Medicaid Outpatient Services for Opioid Use Disorder Was Generally Effective
Medicare Home Health Agency Provider Compliance Audit: Catholic Home Care